Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone

Archives of Neurology

Volumn 65, Issue 5, 2008, Pages 662-665

  Ishiura, Hiroyuki ^a   Morikawa, Masato ^a   Hamada, Masashi ^a   Watanabe, Takuro ^a   Kako, Shinichi ^a   Chiba, Shigeru ^a   Motokura, Toru ^a   Hangaishi, Akira ^a   Shibahara, Junji ^a   Akahane, Masaaki ^a   Goto, Jun ^a   Kwak, Shin ^a   Kurokawa, Mineo ^a   Tsuji, Shoji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTODIAGNOSIS; DISEASE COURSE; DRUG EFFECT; EPSTEIN BARR VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; LABORATORY TEST; LYMPHOMATOID GRANULOMATOSIS; MALE; MONOTHERAPY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SPASTIC PARAPLEGIA; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; BRAIN; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; LUNG; LUNG NEOPLASMS; LYMPHOCYTES; LYMPHOMATOID GRANULOMATOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARAPARESIS, SPASTIC; REMISSION INDUCTION; SPINAL CORD; TREATMENT OUTCOME;

EID: 43549091367     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.5.662     Document Type: Article

References (6)

1. Rao R, Vugman G, Leslie WT, Loew J, Venugopal P. Lymphomatoid granulomatosis treated with rituximab and chemotherapy. Clin Adv Hematol Oncol. 2003;1(11):658-660.
2. Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol. 2003;56(7):555-557.
3. Zaidi A, Kampalath B, Peltier WL, Vesole DH. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma. 2004;45(4):777-780.
4. Jordan K, Grothey A, Grothe W, Kegel T, Wolf HH, Schmoll HG. Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol. 2005;74(3):263-266.
5. Patsalides AD, Atac G, Hedge U, et al. Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging. Radiology. 2005;237(1):265-273.
6. Rubenstein JL, Combs D, Rosenberg J, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2003;101(2):466-468.